297 related articles for article (PubMed ID: 8453644)
41. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
42. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
He Q; Chen J; Lin HL; Hu PJ; Chen MH
Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients.
Gao D; Du J; Cong L; Liu Q
Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036
[TBL] [Abstract][Full Text] [Related]
44. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
45. Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer.
Osanai T; Takagi Y; Toriya Y; Nakagawa T; Aruga T; Iida S; Uetake H; Sugihara K
Jpn J Clin Oncol; 2005 Mar; 35(3):121-5. PubMed ID: 15741301
[TBL] [Abstract][Full Text] [Related]
46. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
47. E-cadherin expression in invasive breast cancer.
Suciu C; Cîmpean AM; Mureşan AM; Izvernariu D; Raica M
Rom J Morphol Embryol; 2008; 49(4):517-23. PubMed ID: 19050801
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
49. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
50. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
51. [Correlation between the expression of urokinase-type plasminogen activator, E-cadherin and malignancy in gastric cancer].
Itoh H; Yonemura Y; Tsuchihara K; Kawamura T; Nojima N; Kaji M; Fushida S; Nishimura G; Fujimura T; Miwa K
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():124-9. PubMed ID: 7611774
[TBL] [Abstract][Full Text] [Related]
52. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
53. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff JR; Herman JG; Lapidus RG; Chopra H; Xu R; Jarrard DF; Isaacs WB; Pitha PM; Davidson NE; Baylin SB
Cancer Res; 1995 Nov; 55(22):5195-9. PubMed ID: 7585573
[TBL] [Abstract][Full Text] [Related]
54. Expression of immunoreactive E-cadherin adhesion molecules in human cancers.
Shiozaki H; Tahara H; Oka H; Miyata M; Kobayashi K; Tamura S; Iihara K; Doki Y; Hirano S; Takeichi M
Am J Pathol; 1991 Jul; 139(1):17-23. PubMed ID: 1713020
[TBL] [Abstract][Full Text] [Related]
55. [A study of the relationship between the expression of connexin43, E-cadherin and biological behaviors of human laryngeal cancer].
Sun WH; Liu HM; Li YJ; Ji XR; Liang DP
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):293-7. PubMed ID: 15338868
[TBL] [Abstract][Full Text] [Related]
56. DNA ploidy of human breast cancer.
Del Bino G; Silvestrini R; Zucconi MR; Marchese G; Valentinis B; Di Fronzo G; Andreola S
Anal Cell Pathol; 1989 Aug; 1(4):215-23. PubMed ID: 2487046
[TBL] [Abstract][Full Text] [Related]
57. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line.
Doki Y; Shiozaki H; Tahara H; Inoue M; Oka H; Iihara K; Kadowaki T; Takeichi M; Mori T
Cancer Res; 1993 Jul; 53(14):3421-6. PubMed ID: 8324752
[TBL] [Abstract][Full Text] [Related]
58. [E-cadherin expression and cancer invasion and metastasis].
Shiozaki H; Doki Y; Oka H; Iihara K; Miyata M; Kadowaki T; Matsui S; Tamura S; Inoue M; Mori T
Hum Cell; 1993 Jun; 6(2):94-9. PubMed ID: 8217956
[TBL] [Abstract][Full Text] [Related]
59. Role of Sphk1 in the malignant transformation of breast epithelial cells and breast cancer progression.
Zheng XD; Zhang Y; Qi XW; Wang MH; Sun P; Zhang Y; Jiang J
Indian J Cancer; 2014; 51(4):524-9. PubMed ID: 26842184
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of e-cadherin in primary breast cancer and corresponding lymph node metastases.
Fulga V; Rudico L; Balica AR; Cimpean AM; Saptefrati L; Margan MM; Raica M
Anticancer Res; 2015 Feb; 35(2):759-65. PubMed ID: 25667455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
